Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. News
  7. Summary
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote Bombay Stock Exchange  -  2022-09-26
689.50 INR   -0.29%
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Transcript : Eris Lifesciences Limited, Q1 2023 Earnings Call, Aug 05, 2022

08/05/2022 | 06:30am EDT
Ladies and gentlemen, good day, and welcome to the Eris Lifesciences Limited Q1 FY '23 Earnings Conference Call. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director;...


© S&P Capital IQ 2022
All news about ERIS LIFESCIENCES LIMITED
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
08/05Transcript : Eris Lifesciences Limited, Q1 2023 Earnings Call, Aug 05, 2022
CI
08/05Eris Lifesciences Limited Declares Interim Dividend for the Financial Year 2022-2023, P..
CI
08/05Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30,..
CI
08/02Eris Lifesciences Board to Consider Interim Dividend for Fiscal 2023
MT
07/20Eris Lifesciences : Resignation
PU
07/20Eris Lifesciences Limited Announces Resignation of Vijaya Sampath as Independent Direct..
CI
07/18Eris Lifesciences : Schedule of Analysts/Institutional Investor Meet/Con. Call
PU
More news
Financials
Sales 2023 17 276 M 212 M 212 M
Net income 2023 4 213 M 51,6 M 51,6 M
Net Debt 2023 4 214 M 51,6 M 51,6 M
P/E ratio 2023 22,3x
Yield 2023 0,99%
Capitalization 93 766 M 1 148 M 1 148 M
EV / Sales 2023 5,67x
EV / Sales 2024 4,76x
Nbr of Employees 3 400
Free-Float 21,2%
Chart ERIS LIFESCIENCES LIMITED
Duration : Period :
Eris Lifesciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERIS LIFESCIENCES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 689,50 INR
Average target price 858,33 INR
Spread / Average Target 24,5%
EPS Revisions
Managers and Directors
Amit Indubhushan Bakshi Chairman & Managing Director
Vijay S. Joshi President
Sachin Shah Senior Manager-Finance & Processes
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director
Milind Talegaonkar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ERIS LIFESCIENCES LIMITED-9.14%1 148
JOHNSON & JOHNSON-3.58%435 655
ELI LILLY AND COMPANY11.32%292 179
ROCHE HOLDING AG-19.31%253 262
ABBVIE INC.4.29%249 673
PFIZER, INC.-25.33%245 989